title: [Vascular purpura and cryoglobulinémia: the difficulties of pharmacovigilance].
authors.forename: L
authors.initials: L
authors.lastname: Sentenac
authors.forename: O
authors.initials: O
authors.lastname: Chassany
authors.forename: E
authors.initials: E
authors.lastname: Mathieu
authors.forename: B
authors.initials: B
authors.lastname: Guillot-Raimbaud
authors.forename: M L
authors.initials: ML
authors.lastname: Efthymiou
authors.forename: C
authors.initials: C
authors.lastname: Caulin
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D003449:Cryoglobulinemia / Q000209:etiology; D005260:Female; D006801:Humans; D011695:IgA Vasculitis / Q000139:chemically induced*; D015575:Roxithromycin / Q000009:adverse effects*
chemical_list: D000900:Anti-Bacterial Agents; D015575:Roxithromycin
vernacular_title: Purpura vasculaire et cryoglobulinémie: les difficultés de la pharmacovigilance.